InterventionsHuman trial48 weeksRandomised trial

Distinct metabolomic signatures of SGLT2 inhibitor vs. sulfonylurea in a paired human liver biopsy study

Graphical abstract from Biochemistry and Biophysics Reports
Open the figure at full size
Graphical abstractTakeshita et al.

Biochemistry and Biophysics Reports

The paper

Takeshita Y, Oo HK, Nakano Y et al.

Biochemistry and Biophysics Reports · 14 Sep 2026

doi.org/10.1016/j.bbrep.2026.102784PubMed 42774780

More on Metabolic dysfunction-associated steatotic liver disease